Skip to main navigation Skip to search Skip to main content

Effects of rosiglitazone, an antidiabetic drug, on Kv3.1 channels

Research output: Contribution to journalJournal articlepeer-review

Original languageKorean
JournalTHE KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
StatePublished - 2023.01.1

Cite this